-
1
-
-
80053339008
-
An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases
-
3229841, 21898493
-
Ghany MG, Nelson DR, Strader DB, Thomas DL, Seeff LB. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011, 54:1433-1444. 10.1002/hep.24641, 3229841, 21898493.
-
(2011)
Hepatology
, vol.54
, pp. 1433-1444
-
-
Ghany, M.G.1
Nelson, D.R.2
Strader, D.B.3
Thomas, D.L.4
Seeff, L.B.5
-
2
-
-
84909629951
-
The Burden of liver disease in Europe. A review of available epidemiological data
-
Blachier M, Leleu H, Peck-Radosavljevic M, Valla D, Roudot-Thoraval F. The Burden of liver disease in Europe. A review of available epidemiological data. [http://www.easl.eu/assets/application/files/54ae845caec619f_file.pdf].
-
-
-
Blachier, M.1
Leleu, H.2
Peck-Radosavljevic, M.3
Valla, D.4
Roudot-Thoraval, F.5
-
3
-
-
59149085501
-
The global burden of hepatitis C
-
Lavanchy D. The global burden of hepatitis C. Liver Int 2009, 29(Suppl 1):74-81.
-
(2009)
Liver Int
, vol.29
, pp. 74-81
-
-
Lavanchy, D.1
-
4
-
-
84894354149
-
Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association
-
3891474, 23714072
-
Hope VD, Eramova I, Capurro D, Donghoe MC. Prevalence and estimation of hepatitis B and C infections in the WHO European Region: a review of data focusing on the countries outside the European Union and the European Free Trade Association. Epidemiol Infect 2014, 142:270-286. 10.1017/S0950268813000940, 3891474, 23714072.
-
(2014)
Epidemiol Infect
, vol.142
, pp. 270-286
-
-
Hope, V.D.1
Eramova, I.2
Capurro, D.3
Donghoe, M.C.4
-
5
-
-
34249341941
-
Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study
-
1955506, 17344277
-
Neal KR. Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study. Gut 2007, 56:1098-1104. 10.1136/gut.2006.113217, 1955506, 17344277.
-
(2007)
Gut
, vol.56
, pp. 1098-1104
-
-
Neal, K.R.1
-
6
-
-
84857144025
-
The Increasing Burden of Mortality From Viral Hepatitis in the United States Between 1999 and 2007
-
22351712
-
Ly KN, Xing J, Klevens RM, Jiles RB, Ward JW, Holmberg SD. The Increasing Burden of Mortality From Viral Hepatitis in the United States Between 1999 and 2007. Ann Intern Med 2012, 156:271. 10.7326/0003-4819-156-4-201202210-00004, 22351712.
-
(2012)
Ann Intern Med
, vol.156
, pp. 271
-
-
Ly, K.N.1
Xing, J.2
Klevens, R.M.3
Jiles, R.B.4
Ward, J.W.5
Holmberg, S.D.6
-
7
-
-
84858295907
-
Standardization of terminology of virological response in the treatment of chronic hepatitis C: panel recommendations
-
Jacobson IM, Poordad F, Brown RS, Kwo PY, Reddy KR, Schiff E. Standardization of terminology of virological response in the treatment of chronic hepatitis C: panel recommendations. J Viral Hepatitis 2012, 19:236-243.
-
(2012)
J Viral Hepatitis
, vol.19
, pp. 236-243
-
-
Jacobson, I.M.1
Poordad, F.2
Brown, R.S.3
Kwo, P.Y.4
Reddy, K.R.5
Schiff, E.6
-
8
-
-
84856410313
-
Antiviral strategies in hepatitis C virus infection
-
Sarrazin C, Hézode C, Zeuzem S, Pawlotsky J. Antiviral strategies in hepatitis C virus infection. J Hepatol 2012, 56:S88-S100.
-
(2012)
J Hepatol
, vol.56
, pp. S88-S100
-
-
Sarrazin, C.1
Hézode, C.2
Zeuzem, S.3
Pawlotsky, J.4
-
9
-
-
84872565980
-
Comparative effectiveness of antiviral treatment for hepatitis C virus infection in adults: a systematic review
-
23437439
-
Chou R, Hartung D, Rahman B, Wasson N, Cottrell EB, Fu R. Comparative effectiveness of antiviral treatment for hepatitis C virus infection in adults: a systematic review. Ann Intern Med 2013, 158:114-123. 10.7326/0003-4819-158-2-201301150-00576, 23437439.
-
(2013)
Ann Intern Med
, vol.158
, pp. 114-123
-
-
Chou, R.1
Hartung, D.2
Rahman, B.3
Wasson, N.4
Cottrell, E.B.5
Fu, R.6
-
10
-
-
84873580144
-
Telaprevir Versus Boceprevir in Chronic Hepatitis C: A Meta-Analysis of Data From Phase II and III Trials
-
23369368
-
Sitole M, Silva M, Spooner L, Comee MK, Malloy M. Telaprevir Versus Boceprevir in Chronic Hepatitis C: A Meta-Analysis of Data From Phase II and III Trials. Clin Ther 2013, 35:190-197. 10.1016/j.clinthera.2012.12.017, 23369368.
-
(2013)
Clin Ther
, vol.35
, pp. 190-197
-
-
Sitole, M.1
Silva, M.2
Spooner, L.3
Comee, M.K.4
Malloy, M.5
-
11
-
-
84858189451
-
Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir
-
Moradpour D, Müllhaupt B, Swiss Association for the Study of the Liver [SASL] Treatment of chronic hepatitis C genotype 1 with triple therapy comprising telaprevir or boceprevir. Swiss Med Wkly 2012, 142:w13516. Swiss Association for the Study of the Liver [SASL].
-
(2012)
Swiss Med Wkly
, vol.142
, pp. w13516
-
-
Moradpour, D.1
Müllhaupt, B.2
-
12
-
-
84855209804
-
Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow
-
Asselah T, Marcellin P. Direct acting antivirals for the treatment of chronic hepatitis C: one pill a day for tomorrow. Liver Int 2012, 32:88-102.
-
(2012)
Liver Int
, vol.32
, pp. 88-102
-
-
Asselah, T.1
Marcellin, P.2
-
13
-
-
84868596510
-
Accessing Hepatitis C patients who are difficult to reach: it is time to overcome barriers
-
Bruggmann P. Accessing Hepatitis C patients who are difficult to reach: it is time to overcome barriers. J Viral Hepatitis 2012, 19:829-8.
-
(2012)
J Viral Hepatitis
, vol.19
, pp. 829-838
-
-
Bruggmann, P.1
-
14
-
-
84903814910
-
Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: insights from the ETHOS study
-
Treloar C, Rance J, Dore GJ, Grebely J. Barriers and facilitators for assessment and treatment of hepatitis C virus infection in the opioid substitution treatment setting: insights from the ETHOS study. J Viral Hepatitis 2014, 21:560-567.
-
(2014)
J Viral Hepatitis
, vol.21
, pp. 560-567
-
-
Treloar, C.1
Rance, J.2
Dore, G.J.3
Grebely, J.4
-
15
-
-
0037179698
-
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
-
12324553
-
Fried MW, Shiffman ML, Reddy R, Smith C, Marinos Cea. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002, 347:975-982. 10.1056/NEJMoa020047, 12324553.
-
(2002)
N Engl J Med
, vol.347
, pp. 975-982
-
-
Fried, M.W.1
Shiffman, M.L.2
Reddy, R.3
Smith, C.4
Cea, M.5
-
16
-
-
84871408060
-
Hepatitis C: Management of Side Effects in the Era of Direct-Acting Antivirals
-
Gaetano JN, Reau N. Hepatitis C: Management of Side Effects in the Era of Direct-Acting Antivirals. Curr Gastroenterol Rep 2013, 15(1):305.
-
(2013)
Curr Gastroenterol Rep
, vol.15
, Issue.1
, pp. 305
-
-
Gaetano, J.N.1
Reau, N.2
-
17
-
-
79952698204
-
Management of Hepatitis C Antiviral Therapy Adverse Effects
-
Sung H, Chang M, Saab S. Management of Hepatitis C Antiviral Therapy Adverse Effects. Curr Hepatol Rep 2011, 10:33-40.
-
(2011)
Curr Hepatol Rep
, vol.10
, pp. 33-40
-
-
Sung, H.1
Chang, M.2
Saab, S.3
-
18
-
-
84873275651
-
Eligibility and Safety of Triple Therapy for Hepatitis C: Lessons Learned from the First Experience in a Real World Setting
-
3562338, 23383319
-
Maasoumy B, Port K, Markova AA, Serrano BC, Rogalska-Taranta M, Sollik L, Mix C, Kirschner J, Manns MP, Wedemeyer H, Cornberg M, Tavis JE. Eligibility and Safety of Triple Therapy for Hepatitis C: Lessons Learned from the First Experience in a Real World Setting. PLoS ONE 2013, 8:e55285. 10.1371/journal.pone.0055285, 3562338, 23383319.
-
(2013)
PLoS ONE
, vol.8
, pp. e55285
-
-
Maasoumy, B.1
Port, K.2
Markova, A.A.3
Serrano, B.C.4
Rogalska-Taranta, M.5
Sollik, L.6
Mix, C.7
Kirschner, J.8
Manns, M.P.9
Wedemeyer, H.10
Cornberg, M.11
Tavis, J.E.12
-
19
-
-
0042090615
-
Self-management education: history, definition, outcomes, and mechanisms
-
Lorig KR, Holman HR. Self-management education: history, definition, outcomes, and mechanisms. Ann Intern Med 2003, 26:1-7.
-
(2003)
Ann Intern Med
, vol.26
, pp. 1-7
-
-
Lorig, K.R.1
Holman, H.R.2
-
20
-
-
1542465181
-
The structure of everyday self-care decision making in chronic illness
-
14658350
-
Thorne S, Paterson B, Russel C. The structure of everyday self-care decision making in chronic illness. Qual Health Res 2003, 13:1337-1352. 10.1177/1049732303258039, 14658350.
-
(2003)
Qual Health Res
, vol.13
, pp. 1337-1352
-
-
Thorne, S.1
Paterson, B.2
Russel, C.3
-
21
-
-
68149132783
-
Living with hepatitis C and treatment: the personal experiences of patients
-
19583661
-
Sgorbini M, O'Brien L, Jackson D. Living with hepatitis C and treatment: the personal experiences of patients. J Clin Nurs 2009, 18:2282-2291. 10.1111/j.1365-2702.2009.02806.x, 19583661.
-
(2009)
J Clin Nurs
, vol.18
, pp. 2282-2291
-
-
Sgorbini, M.1
O'Brien, L.2
Jackson, D.3
-
22
-
-
84859339341
-
The tasks of self-managing hepatitis C: The significance of disclosure
-
21736430
-
Fry M, Bates G. The tasks of self-managing hepatitis C: The significance of disclosure. Psychol Health 2012, 27:460-474. 10.1080/08870446.2011.592982, 21736430.
-
(2012)
Psychol Health
, vol.27
, pp. 460-474
-
-
Fry, M.1
Bates, G.2
-
23
-
-
84864379047
-
[Hepatitis C! Experience in diagnosis and medical treatment. A literature review]
-
22661065
-
Künzler-Heule P, Panfil E. [Hepatitis C! Experience in diagnosis and medical treatment. A literature review]. Pflege 2012, 25:185-195. 10.1024/1012-5302/a000201, 22661065.
-
(2012)
Pflege
, vol.25
, pp. 185-195
-
-
Künzler-Heule, P.1
Panfil, E.2
-
24
-
-
84870486860
-
Adherence to Longterm Therapies: Evidence for Action
-
World Health Organization [WHO] Adherence to Longterm Therapies: Evidence for Action. [http://www.who.int/chp/knowledge/publications/adherence:report/en/], World Health Organization [WHO].
-
-
-
-
25
-
-
80052955087
-
Relationship between adherence to Hepatitis C Virus Therapy and virologic outcomes, Cohort Study
-
3366635, 21930852
-
Lo Re V, Teal V, Localio AR, Amorosa VK, Kapalan DE. Relationship between adherence to Hepatitis C Virus Therapy and virologic outcomes, Cohort Study. Ann Intern Med 2011, 155(6):353-360. 10.7326/0003-4819-155-6-201109200-00003, 3366635, 21930852.
-
(2011)
Ann Intern Med
, vol.155
, Issue.6
, pp. 353-360
-
-
Lo Re, V.1
Teal, V.2
Localio, A.R.3
Amorosa, V.K.4
Kapalan, D.E.5
-
26
-
-
79952467802
-
Adherence to treatment and quality of life during hepatitis C therapy: a prospective, real-life, observational study
-
21382162
-
Marcellin P, Chousterman M, Fontanges T, Ouzan D, Rotily M, Varastet M, Lang J, Melin P, Cacoub P. Adherence to treatment and quality of life during hepatitis C therapy: a prospective, real-life, observational study. Liver Int 2011, 31:516-524. 10.1111/j.1478-3231.2011.02461.x, 21382162.
-
(2011)
Liver Int
, vol.31
, pp. 516-524
-
-
Marcellin, P.1
Chousterman, M.2
Fontanges, T.3
Ouzan, D.4
Rotily, M.5
Varastet, M.6
Lang, J.7
Melin, P.8
Cacoub, P.9
-
27
-
-
84878799939
-
Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirin
-
23710734
-
Gordon SC, Yoshida EM, Lawitz EJ, Bacon BR, Sulkowski MS, Davis M, Poordad F, Bronowicki J, Esteban R, Sniukiene V, Burroughs MH, Deng W, Dutko FJ, Brass CA, Albrecht JK, Rajender Reddy K. Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirin. Aliment Pharmacol Ther 2013, 38:16-27. 10.1111/apt.12342, 23710734.
-
(2013)
Aliment Pharmacol Ther
, vol.38
, pp. 16-27
-
-
Gordon, S.C.1
Yoshida, E.M.2
Lawitz, E.J.3
Bacon, B.R.4
Sulkowski, M.S.5
Davis, M.6
Poordad, F.7
Bronowicki, J.8
Esteban, R.9
Sniukiene, V.10
Burroughs, M.H.11
Deng, W.12
Dutko, F.J.13
Brass, C.A.14
Albrecht, J.K.15
Rajender Reddy, K.16
-
28
-
-
84864206329
-
Impact of adverse events on costs and quality of life in protease inhibitor-based combination therapy for hepatitis C
-
22812557
-
Gao X, Stephens JM, Carter JA, Haider S, Rustgi VK. Impact of adverse events on costs and quality of life in protease inhibitor-based combination therapy for hepatitis C. Expert Rev Pharmacoecon Outcomes Res 2012, 12:335-343. 10.1586/erp.12.10, 22812557.
-
(2012)
Expert Rev Pharmacoecon Outcomes Res
, vol.12
, pp. 335-343
-
-
Gao, X.1
Stephens, J.M.2
Carter, J.A.3
Haider, S.4
Rustgi, V.K.5
-
29
-
-
84855935309
-
The critical role of medication adherence in the success of boceprevir and telaprevir in clinical practice
-
21718669
-
Weiss JJ, Alcorn MC, Rabkin JG, Dieterich DT. The critical role of medication adherence in the success of boceprevir and telaprevir in clinical practice. J Hepatol 2012, 56:503-504. 10.1016/j.jhep.2011.05.014, 21718669.
-
(2012)
J Hepatol
, vol.56
, pp. 503-504
-
-
Weiss, J.J.1
Alcorn, M.C.2
Rabkin, J.G.3
Dieterich, D.T.4
-
30
-
-
84907908311
-
Interventions To Improve Patient Adherence to Hepatitis C Treatment: Comparative Effectiveness Review No. 91
-
Rockville, MD: Agency for Healthcare Research and Quality
-
Sun X, Patnode CD, Williams C, Senger CA, Kapka TJ, Whitlock EW. Interventions To Improve Patient Adherence to Hepatitis C Treatment: Comparative Effectiveness Review No. 91. Prepared by the Oregon Evidencebased Practice Center under Contract No. 290-2007-10057-I 2012, Rockville, MD: Agency for Healthcare Research and Quality.
-
(2012)
Prepared by the Oregon Evidencebased Practice Center under Contract No. 290-2007-10057-I
-
-
Sun, X.1
Patnode, C.D.2
Williams, C.3
Senger, C.A.4
Kapka, T.J.5
Whitlock, E.W.6
-
31
-
-
84887544404
-
The Hepatitis C Self-Management Program: Sustainability of Primary Outcomes at 1 Year
-
23445604
-
Groessl EJ, Ho SB, Asch SM, Stepnowsky CJ, Laurent D, Gifford AL. The Hepatitis C Self-Management Program: Sustainability of Primary Outcomes at 1 Year. Health Educ Behav 2013, 40:730-740. 10.1177/1090198113477112, 23445604.
-
(2013)
Health Educ Behav
, vol.40
, pp. 730-740
-
-
Groessl, E.J.1
Ho, S.B.2
Asch, S.M.3
Stepnowsky, C.J.4
Laurent, D.5
Gifford, A.L.6
-
32
-
-
84879806759
-
Increasing antiviral treatment through integrated hepatitis C care: A randomized multicenter trial
-
Groessl EJ, Sklar M, Cheung RC, Bräu N, Ho SB. Increasing antiviral treatment through integrated hepatitis C care: A randomized multicenter trial. Contemp Clin Trials 2013, 35:97-107.
-
(2013)
Contemp Clin Trials
, vol.35
, pp. 97-107
-
-
Groessl, E.J.1
Sklar, M.2
Cheung, R.C.3
Bräu, N.4
Ho, S.B.5
-
33
-
-
84907917209
-
Executive Summary of ASMP/CDSMP Meta Analysis
-
Brady TJ, Murphy L. Executive Summary of ASMP/CDSMP Meta Analysis. [http://www.cdc.gov/arthritis/docs/ASMP-executive-summary.pdf].
-
-
-
Brady, T.J.1
Murphy, L.2
-
34
-
-
84861117640
-
Helping the people help themselves. A review of the evidence considering whether it is worthwhile to support self-management
-
DeSilva D. Helping the people help themselves. A review of the evidence considering whether it is worthwhile to support self-management. [http://www.health.org.uk/public/cms/75/76/313/2434/Helping%20people%20help%20themselves.pdf?realName=8mh12J.pdf].
-
-
-
DeSilva, D.1
-
35
-
-
84873403998
-
Adherence and Completion in Hepatitis C Management
-
23364367
-
Redulla R, Dudley-Brown S. Adherence and Completion in Hepatitis C Management. Gastroenterol Nurs 2013, 36:53-58. 10.1097/SGA.0b013e318281634e, 23364367.
-
(2013)
Gastroenterol Nurs
, vol.36
, pp. 53-58
-
-
Redulla, R.1
Dudley-Brown, S.2
-
36
-
-
84904707593
-
EASL Recommendations on Treatment of Hepatitis C 2014
-
European Assosciation for the study of the liver EASL Recommendations on Treatment of Hepatitis C 2014. J Hepatol 2014, 61:373-395. European Assosciation for the study of the liver.
-
(2014)
J Hepatol
, vol.61
, pp. 373-395
-
-
-
38
-
-
33750505977
-
Using thematic analysis in psychology
-
Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006, 3:77-101.
-
(2006)
Qual Res Psychol
, vol.3
, pp. 77-101
-
-
Braun, V.1
Clarke, V.2
-
40
-
-
79953123168
-
Toward Methodological Emancipation in Applied Health Research
-
21164035
-
Thorne S. Toward Methodological Emancipation in Applied Health Research. Qual Health Res 2011, 21:443-453. 10.1177/1049732310392595, 21164035.
-
(2011)
Qual Health Res
, vol.21
, pp. 443-453
-
-
Thorne, S.1
-
41
-
-
0030453840
-
Sampling for qualitative research
-
Marshall MN. Sampling for qualitative research. J Fam Practice 1996, 13:522-525.
-
(1996)
J Fam Practice
, vol.13
, pp. 522-525
-
-
Marshall, M.N.1
-
42
-
-
84880966007
-
Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs
-
Robaeys G, Grebely J, Mauss S, Bruggmann P, Moussalli J, de Gottardi A, Swan T, Arain A, Kautz A, Stover H, Wedemeyer H, Schaefer M, Taylor L, Backmund M, Dalgard O, Prins M, Dore GJ. Recommendations for the Management of Hepatitis C Virus Infection Among People Who Inject Drugs. Clin Infect Dis 2013, 57(Suppl 2):129-137.
-
(2013)
Clin Infect Dis
, vol.57
, pp. 129-137
-
-
Robaeys, G.1
Grebely, J.2
Mauss, S.3
Bruggmann, P.4
Moussalli, J.5
de Gottardi, A.6
Swan, T.7
Arain, A.8
Kautz, A.9
Stover, H.10
Wedemeyer, H.11
Schaefer, M.12
Taylor, L.13
Backmund, M.14
Dalgard, O.15
Prins, M.16
Dore, G.J.17
-
43
-
-
84867714206
-
Patterns and predictors of treatment initiation and completion in patients with chronic hepatitis C virus infection
-
3333810, 22536063
-
Clark B, Garcia-Tsao F. Patterns and predictors of treatment initiation and completion in patients with chronic hepatitis C virus infection. Patient Prefer Adherence 2012, 6:285-295. 3333810, 22536063.
-
(2012)
Patient Prefer Adherence
, vol.6
, pp. 285-295
-
-
Clark, B.1
Garcia-Tsao, F.2
-
44
-
-
84878008414
-
Assessment of motivating factors associated with the initiation and completion of treatment for chronic hepatitis C virus (HCV) infection
-
Fusfeld L, Aggarwal J, Dougher C, Vera-Llonch M, Bubb Sea. Assessment of motivating factors associated with the initiation and completion of treatment for chronic hepatitis C virus (HCV) infection. BMC Infec Dis 2013, 13:234.
-
(2013)
BMC Infec Dis
, vol.13
, pp. 234
-
-
Fusfeld, L.1
Aggarwal, J.2
Dougher, C.3
Vera-Llonch, M.4
Sea, B.5
-
45
-
-
84859067322
-
New therapies for chronic hepatitis C infection: a systematic review of evidence from clinical trials
-
22420497
-
Lee LY, Tong CY, Wong T, Wilkinson M. New therapies for chronic hepatitis C infection: a systematic review of evidence from clinical trials. Int J Clin Pract 2012, 66:342-355. 10.1111/j.1742-1241.2012.02895.x, 22420497.
-
(2012)
Int J Clin Pract
, vol.66
, pp. 342-355
-
-
Lee, L.Y.1
Tong, C.Y.2
Wong, T.3
Wilkinson, M.4
-
46
-
-
57649096278
-
'If it almost kills you that means it's working!' Cultural models of chemotherapy expressed in a cancer support group
-
19010578
-
Bell K. 'If it almost kills you that means it's working!' Cultural models of chemotherapy expressed in a cancer support group. Soc Sci Med 2009, 68:169-176. 10.1016/j.socscimed.2008.10.023, 19010578.
-
(2009)
Soc Sci Med
, vol.68
, pp. 169-176
-
-
Bell, K.1
-
47
-
-
84872039392
-
How to optimize HCV therapy in genotype 1 patients: management of side-effects
-
Chopra A, Klein PL, Drinnan T, Lee SS. How to optimize HCV therapy in genotype 1 patients: management of side-effects. Liver Int 2013, 33:30-34.
-
(2013)
Liver Int
, vol.33
, pp. 30-34
-
-
Chopra, A.1
Klein, P.L.2
Drinnan, T.3
Lee, S.S.4
-
48
-
-
18044404277
-
Advancing the science of symptom management
-
11298204
-
Dodd M, Janson S, Facione N, Faucett J, Froelicher ES, Humphreys J, Lee K, Miaskowski C, Puntillo K, Rankin S, Taylor D. Advancing the science of symptom management. J Adv Nurs 2001, 33:668-676. 10.1046/j.1365-2648.2001.01697.x, 11298204.
-
(2001)
J Adv Nurs
, vol.33
, pp. 668-676
-
-
Dodd, M.1
Janson, S.2
Facione, N.3
Faucett, J.4
Froelicher, E.S.5
Humphreys, J.6
Lee, K.7
Miaskowski, C.8
Puntillo, K.9
Rankin, S.10
Taylor, D.11
-
49
-
-
84871311662
-
Perceived HIV symptom manageability: synthesis of a new use for a known concept
-
22765386
-
Fierz K, Nicca D, Spirig R. Perceived HIV symptom manageability: synthesis of a new use for a known concept. J Adv Nurs 2013, 69:229-241. 10.1111/j.1365-2648.2012.06068.x, 22765386.
-
(2013)
J Adv Nurs
, vol.69
, pp. 229-241
-
-
Fierz, K.1
Nicca, D.2
Spirig, R.3
-
50
-
-
65949105534
-
A middle range theory of symptom management
-
New York: Springer Publishing Co, Smith MJ, Liehr PR, 3
-
Humphreys J, Janson S, Donesky D, Dracup K, Lee LA, Puntillo K, Faucett J, Aouizerat B, Miaskowski C, Baggott C, Carrieri-Kohlman V, Barger M, Franck L, Kennedy C. A middle range theory of symptom management. Middle range theory for nursing 2014, 141-164. New York: Springer Publishing Co, Smith MJ, Liehr PR, 3.
-
(2014)
Middle range theory for nursing
, pp. 141-164
-
-
Humphreys, J.1
Janson, S.2
Donesky, D.3
Dracup, K.4
Lee, L.A.5
Puntillo, K.6
Faucett, J.7
Aouizerat, B.8
Miaskowski, C.9
Baggott, C.10
Carrieri-Kohlman, V.11
Barger, M.12
Franck, L.13
Kennedy, C.14
-
51
-
-
33745736074
-
Living with chronic hepatitis C means 'you just haven't got a normal life any more'
-
Conrad S, Garrett LE, Cooksley WGE, Dunne MP, McDonald GA. Living with chronic hepatitis C means 'you just haven't got a normal life any more'. Chronic Illness 2006, 2:121-131.
-
(2006)
Chronic Illness
, vol.2
, pp. 121-131
-
-
Conrad, S.1
Garrett, L.E.2
Cooksley, W.G.E.3
Dunne, M.P.4
McDonald, G.A.5
-
52
-
-
84881330219
-
Relationship between HIV stigma mechanisms and well-being among PLWH: a test of the HIV stigma framework
-
3738573, 23950897
-
Audet CM, McGowan CC, Wallston KA, Kipp Aaron M. Relationship between HIV stigma mechanisms and well-being among PLWH: a test of the HIV stigma framework. PLoS ONE 2013, 8:e69564. 10.1371/journal.pone.0069564, 3738573, 23950897.
-
(2013)
PLoS ONE
, vol.8
, pp. e69564
-
-
Audet, C.M.1
McGowan, C.C.2
Wallston, K.A.3
Kipp Aaron, M.4
-
53
-
-
84878560450
-
HIV Stigma Mechanisms and Well-Being Among PLWH: A Test of the HIV Stigma Framework
-
3664141, 23456594
-
Earnshaw VA, Smith LR, Chaudoir SR, Amico KR, Copenhaver MM. HIV Stigma Mechanisms and Well-Being Among PLWH: A Test of the HIV Stigma Framework. AIDS Behav 2013, 17:1785-1795. 10.1007/s10461-013-0437-9, 3664141, 23456594.
-
(2013)
AIDS Behav
, vol.17
, pp. 1785-1795
-
-
Earnshaw, V.A.1
Smith, L.R.2
Chaudoir, S.R.3
Amico, K.R.4
Copenhaver, M.M.5
-
54
-
-
84889246609
-
Patient perspectives on hepatitis C and its treatment
-
North CS, Devereaux R, Pollio DE, Hong BA, Jain MK. Patient perspectives on hepatitis C and its treatment. Eur J Gastroen Hepat 2014, 26:74-81.
-
(2014)
Eur J Gastroen Hepat
, vol.26
, pp. 74-81
-
-
North, C.S.1
Devereaux, R.2
Pollio, D.E.3
Hong, B.A.4
Jain, M.K.5
-
55
-
-
84867671977
-
Empirical Studies of Self-Stigma Reduction Strategies: A Critical Review of the Literature
-
Mittal D, Sullivan G, Chekuri L, Allee E, Corrigan PW. Empirical Studies of Self-Stigma Reduction Strategies: A Critical Review of the Literature. Psych Serv 2012, 63:974-981.
-
(2012)
Psych Serv
, vol.63
, pp. 974-981
-
-
Mittal, D.1
Sullivan, G.2
Chekuri, L.3
Allee, E.4
Corrigan, P.W.5
-
56
-
-
84860243899
-
Help-seeking and coping with the psychosocial burden of chronic hepatitis C: a qualitative study of patient, hepatologist, and counsellor perspectives
-
22154094
-
Stewart BJ, Mikocka-Walus AA, Harley H, Andrews JM. Help-seeking and coping with the psychosocial burden of chronic hepatitis C: a qualitative study of patient, hepatologist, and counsellor perspectives. INT J NURS STUD 2012, 49:560-569. 10.1016/j.ijnurstu.2011.11.004, 22154094.
-
(2012)
INT J NURS STUD
, vol.49
, pp. 560-569
-
-
Stewart, B.J.1
Mikocka-Walus, A.A.2
Harley, H.3
Andrews, J.M.4
-
57
-
-
9144274620
-
Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study
-
313896, 14703538
-
Young J, Geest de S, Spiring R, Plepp M, Rickenbach Mea. Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study. BMJ 2004, 328:15. 10.1136/bmj.328.7430.15, 313896, 14703538.
-
(2004)
BMJ
, vol.328
, pp. 15
-
-
Young, J.1
Geest de, S.2
Spiring, R.3
Plepp, M.4
Mea, R.5
-
58
-
-
77956938619
-
Patients' perceptions of information and support received from the nurse specialist during HCV treatment
-
20846231
-
Grogan A, Timmins F. Patients' perceptions of information and support received from the nurse specialist during HCV treatment. J CLIN NURS 2010, 19:2869-2878. 10.1111/j.1365-2702.2010.03239.x, 20846231.
-
(2010)
J CLIN NURS
, vol.19
, pp. 2869-2878
-
-
Grogan, A.1
Timmins, F.2
-
59
-
-
80052030968
-
Education by a Nurse Increases Response of Patients With Chronic Hepatitis C to Therapy With Peginterferon-α2a and Ribavirin
-
21683161
-
Larrey D, Salse A, Ribard D, Boutet O, Hyrailles-Blanc V, Niang B, Pageaux GP, Vaucher E, Arpurt JP, Boulay G, Karlova N, Daures JP. Education by a Nurse Increases Response of Patients With Chronic Hepatitis C to Therapy With Peginterferon-α2a and Ribavirin. Clin Gastroenterol Hepatol 2011, 9:781-785. 10.1016/j.cgh.2011.05.022, 21683161.
-
(2011)
Clin Gastroenterol Hepatol
, vol.9
, pp. 781-785
-
-
Larrey, D.1
Salse, A.2
Ribard, D.3
Boutet, O.4
Hyrailles-Blanc, V.5
Niang, B.6
Pageaux, G.P.7
Vaucher, E.8
Arpurt, J.P.9
Boulay, G.10
Karlova, N.11
Daures, J.P.12
-
60
-
-
84888580694
-
Addicts with chronic hepatitis C: Difficult to reach, manage or treat?
-
3848148, 24307794
-
Zanini B, Benini F, Pigozzi M, Garziella, Furba P, Giacò E, Cinquegrana A, Fasoli M, Lanzini A. Addicts with chronic hepatitis C: Difficult to reach, manage or treat?. World J Gastroenterol 2013, 19:8011-8019. 10.3748/wjg.v19.i44.8011, 3848148, 24307794.
-
(2013)
World J Gastroenterol
, vol.19
, pp. 8011-8019
-
-
Zanini, B.1
Benini, F.2
Pigozzi, G.M.3
Furba, P.4
Giacò, E.5
Cinquegrana, A.6
Fasoli, M.7
Lanzini, A.8
-
61
-
-
84928590389
-
Adherence During Antiviral Treatment Regimens for Chronic Hepatitis C: A Qualitative Study of Patient-reported Facilitators and Barriers
-
[Epub ahead of print]
-
Evon DM, Golin CE, Bonner JE, Grodensky C, Velloza J. Adherence During Antiviral Treatment Regimens for Chronic Hepatitis C: A Qualitative Study of Patient-reported Facilitators and Barriers. J Clin Gastroenterol 2014, [Epub ahead of print].
-
(2014)
J Clin Gastroenterol
-
-
Evon, D.M.1
Golin, C.E.2
Bonner, J.E.3
Grodensky, C.4
Velloza, J.5
|